MCE - Delayed Quote EUR
Grifols SA (GRF-P.MC)
6.36
-0.04
(-0.55%)
As of 4:26:55 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
902,168
902,168
218,690
-1,427
596,975
Investing Cash Flow
886,667
886,667
-394,719
-1,996,123
-854,149
Financing Cash Flow
-1,358,714
-1,358,714
171,493
-164,901
2,297,679
End Cash Position
979,780
979,780
529,577
549,207
2,675,611
Capital Expenditure
-371,367
-371,367
-310,320
-392,872
-315,088
Repayment of Debt
-111,488
-111,488
-116,394
-104,287
-82,692
Repurchase of Capital Stock
--
--
--
-3,459
-125,703
Free Cash Flow
530,801
530,801
-91,630
-394,299
281,887
12/31/2021 - 6/3/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
AMGN.MX Amgen Inc.
5,500.00
0.00%
4AB.F AbbVie Inc.
155.80
+0.65%
OPHLY Ono Pharmaceutical Co., Ltd.
4.1500
+5.87%
ORNBVh.XC
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
8.72
+0.11%
NOV.MU Novo Nordisk A/S
54.64
+0.37%
0R34.IL Johnson & Johnson
154.32
-2.27%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,916.75
+2.31%
NOTA.DU Novartis AG
98.00
+1.03%